KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 1,406,431 | $44,837,021 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 12,494 | $398,309 | 0.00% |
| Swiss National Bank | 45,600 | $1,453,728 | 0.00% |
| TD ASSET MANAGEMENT INC | 36,200 | $1,154,056 | 0.00% |
| Tortoise Investment Management, LLC | 312 | $9,947 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 23,267 | $741,752 | 0.00% |
| RHUMBLINE ADVISERS | 32,543 | $1,037,460 | 0.00% |
| NORTHERN TRUST CORP | 212,899 | $6,787,221 | 0.00% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 29,874 | $952,383 | 0.00% |
| CREDIT SUISSE AG/ | 24,799 | $790,593 | 0.00% |
| GOLDMAN SACHS GROUP INC | 100,059 | $3,189,881 | 0.00% |
| MORGAN STANLEY | 448,701 | $14,304,588 | 0.00% |
| AMALGAMATED BANK | 3,329 | $106 | 0.00% |
| Bank of New York Mellon Corp | 144,409 | $4,603,759 | 0.00% |
| Handelsbanken Fonder AB | 6,700 | $214 | 0.00% |
| DekaBank Deutsche Girozentrale | 7,550 | $246 | 0.00% |
| Qube Research & Technologies Ltd | 8,958 | $285,581 | 0.00% |
| Cresset Asset Management, LLC | 7,682 | $244,902 | 0.00% |
| WELLS FARGO & COMPANY/MN | 15,238 | $485,787 | 0.00% |
| CWM, LLC | 55 | $2 | 0.00% |
External links
This page lists KEROS THERAPEUTICS INC's shareholders in Q3 2023. To view KEROS THERAPEUTICS INC's shareholder history, click here.